5svr: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
← Older edit
No edit summary
No edit summary
 
Line 3: Line 3:
<StructureSection load='5svr' size='340' side='right'caption='[[5svr]], [[Resolution|resolution]] 3.13&Aring;' scene=''>
<StructureSection load='5svr' size='340' side='right'caption='[[5svr]], [[Resolution|resolution]] 3.13&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[5svr]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5SVR OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5SVR FirstGlance]. <br>
<table><tr><td colspan='2'>[[5svr]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5SVR OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5SVR FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=71C:5-{[(3-PHENOXYPHENYL)METHYL][(1S)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL]CARBAMOYL}BENZENE-1,2,4-TRICARBOXYLIC+ACID'>71C</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3.13&#8491;</td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[5svj|5svj]], [[5svk|5svk]], [[5svl|5svl]], [[5svm|5svm]], [[5svp|5svp]], [[5svq|5svq]], [[5svs|5svs]], [[5svt|5svt]]</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=71C:5-{[(3-PHENOXYPHENYL)METHYL][(1S)-1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL]CARBAMOYL}BENZENE-1,2,4-TRICARBOXYLIC+ACID'>71C</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">P2RX3 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5svr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5svr OCA], [https://pdbe.org/5svr PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5svr RCSB], [https://www.ebi.ac.uk/pdbsum/5svr PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5svr ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5svr FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5svr OCA], [http://pdbe.org/5svr PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5svr RCSB], [http://www.ebi.ac.uk/pdbsum/5svr PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5svr ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
[[http://www.uniprot.org/uniprot/P2RX3_HUMAN P2RX3_HUMAN]] Receptor for ATP that acts as a ligand-gated ion channel.
[https://www.uniprot.org/uniprot/P2RX3_HUMAN P2RX3_HUMAN] Receptor for ATP that acts as a ligand-gated ion channel.
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
P2X receptors are trimeric, non-selective cation channels activated by ATP that have important roles in the cardiovascular, neuronal and immune systems. Despite their central function in human physiology and although they are potential targets of therapeutic agents, there are no structures of human P2X receptors. The mechanisms of receptor desensitization and ion permeation, principles of antagonism, and complete structures of the pore-forming transmembrane domains of these receptors remain unclear. Here we report X-ray crystal structures of the human P2X3 receptor in apo/resting, agonist-bound/open-pore, agonist-bound/closed-pore/desensitized and antagonist-bound/closed states. The open state structure harbours an intracellular motif we term the 'cytoplasmic cap', which stabilizes the open state of the ion channel pore and creates lateral, phospholipid-lined cytoplasmic fenestrations for water and ion egress. The competitive antagonists TNP-ATP and A-317491 stabilize the apo/resting state and reveal the interactions responsible for competitive inhibition. These structures illuminate the conformational rearrangements that underlie P2X receptor gating and provide a foundation for the development of new pharmacological agents.


X-ray structures define human P2X3 receptor gating cycle and antagonist action.,Mansoor SE, Lu W, Oosterheert W, Shekhar M, Tajkhorshid E, Gouaux E Nature. 2016 Sep 14. doi: 10.1038/nature19367. PMID:27626375<ref>PMID:27626375</ref>
==See Also==
 
*[[Ion channels 3D structures|Ion channels 3D structures]]
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 5svr" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Gouaux, E]]
[[Category: Gouaux E]]
[[Category: Lu, W]]
[[Category: Lu W]]
[[Category: Mansoor, S E]]
[[Category: Mansoor SE]]
[[Category: Oosterheert, W]]
[[Category: Oosterheert W]]
[[Category: Shekhar, M]]
[[Category: Shekhar M]]
[[Category: Tajkhorshid, E]]
[[Category: Tajkhorshid E]]
[[Category: Membrane protein]]
[[Category: Membrane protein ion channel antagonist state]]

Latest revision as of 18:33, 6 March 2024

Crystal structure of the ATP-gated human P2X3 ion channel bound to competitive antagonist A-317491Crystal structure of the ATP-gated human P2X3 ion channel bound to competitive antagonist A-317491

Structural highlights

5svr is a 1 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:X-ray diffraction, Resolution 3.13Å
Ligands:, , ,
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

P2RX3_HUMAN Receptor for ATP that acts as a ligand-gated ion channel.

See Also

5svr, resolution 3.13Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA
Retrieved from "https://proteopedia.openfox.io/wiki/index.php?title=5svr&oldid=4084686"